Chemotherapy and Atezolizumab for Patients with Extensive Stage Small Cell Lung Cancer (SCLC) with Untreated Brain Metastases (HCRN-LUN19-247)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
December 7, 2020
End Date
November 30, 2025
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
December 7, 2020
End Date
November 30, 2025